These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 9299854)
1. Natural and acquired inhibitors of hemostasis in selected symptomatic outpatients with venous thromboembolic disease. Bazzan M; Tamponi G; Vaccarino A; Montaruli B; Aluffi E; Schinco P; Pannocchia A; Borchiellini A; Rabbia C; Pileri A Haematologica; 1997; 82(4):420-2. PubMed ID: 9299854 [TBL] [Abstract][Full Text] [Related]
2. Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study. Mahmoodi BK; Brouwer JL; Veeger NJ; van der Meer J Circulation; 2008 Oct; 118(16):1659-67. PubMed ID: 18824642 [TBL] [Abstract][Full Text] [Related]
3. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. Heijboer H; Brandjes DP; Büller HR; Sturk A; ten Cate JW N Engl J Med; 1990 Nov; 323(22):1512-6. PubMed ID: 2146503 [TBL] [Abstract][Full Text] [Related]
4. Recurrent venous thrombosis and hypercoagulable states. Bolan CD; Alving BM Am Fam Physician; 1991 Nov; 44(5):1741-51. PubMed ID: 1835274 [TBL] [Abstract][Full Text] [Related]
5. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis]. Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836 [TBL] [Abstract][Full Text] [Related]
6. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives. Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614 [TBL] [Abstract][Full Text] [Related]
7. Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet's disease. Mader R; Ziv M; Adawi M; Mader R; Lavi I J Rheumatol; 1999 Nov; 26(11):2404-8. PubMed ID: 10555901 [TBL] [Abstract][Full Text] [Related]
8. [Role of the hemostasis laboratory in the etiologic approach to deep vein thrombosis]. De Maistre E; Briquel ME; Andre E; Regnault V; Whal D; Perret C; Laprevote MC; Lecompte T J Mal Vasc; 1996; 21(1):1-6. PubMed ID: 8656085 [TBL] [Abstract][Full Text] [Related]
9. Parameters of haemostasis during acute venous thrombosis. Reiter W; Ehrensberger H; Steinbrückner B; Keller F Thromb Haemost; 1995 Aug; 74(2):596-601. PubMed ID: 8584990 [TBL] [Abstract][Full Text] [Related]
10. [Activated protein C resistance in patients with venous leg ulcer]. Munkvad S; Jørgensen M Ugeskr Laeger; 1997 Mar; 159(14):2100-2. PubMed ID: 9148535 [TBL] [Abstract][Full Text] [Related]
11. Natural coagulation inhibitory proteins and activated protein C resistance in Turkish patients with inflammatory bowel disease. Payzin B; Adakan FY; Yalçin HC; Cetinkaya GS; Berkmen S; Eraslan S; Unsal B Turk J Gastroenterol; 2006 Sep; 17(3):183-90. PubMed ID: 16941251 [TBL] [Abstract][Full Text] [Related]
12. [Diagnosis of thrombophilia based on coagulation and genetic studies]. Bałszan-Kowalska I Ann Acad Med Stetin; 2002; 48():179-93. PubMed ID: 14601477 [TBL] [Abstract][Full Text] [Related]
13. Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease. Koutroubakis IE; Sfiridaki A; Mouzas IA; Maladaki A; Kapsoritakis A; Roussomoustakaki M; Kouroumalis EA; Manousos ON Am J Gastroenterol; 2000 Jan; 95(1):190-4. PubMed ID: 10638581 [TBL] [Abstract][Full Text] [Related]
14. Acquired activated protein C resistance is associated with IgG antibodies to protein S in patients with systemic lupus erythematosus. Nojima J; Iwatani Y; Ichihara K; Tsuneoka H; Ishikawa T; Yanagihara M; Takano T; Hidaka Y Thromb Res; 2009 May; 124(1):127-31. PubMed ID: 19128822 [TBL] [Abstract][Full Text] [Related]
15. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis. Dahlbck B J Intern Med Suppl; 1997; 740():1-8. PubMed ID: 9350175 [TBL] [Abstract][Full Text] [Related]
16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
17. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome. Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458 [TBL] [Abstract][Full Text] [Related]
18. The search for a common thrombophilic state during the active state of inflammatory bowel disease. Yurekli BP; Aksoy DY; Aybar M; Egesel T; Gurgey A; Hascelik G; Kirazli S; Haznedaroglu IC; Arslan S J Clin Gastroenterol; 2006 Oct; 40(9):809-13. PubMed ID: 17016137 [TBL] [Abstract][Full Text] [Related]
19. Disorders of hemostasis in childhood: risk factors for venous thromboembolism. Manco-Johnson MJ Thromb Haemost; 1997 Jul; 78(1):710-4. PubMed ID: 9198244 [TBL] [Abstract][Full Text] [Related]
20. Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease. Novacek G; Miehsler W; Kapiotis S; Katzenschlager R; Speiser W; Vogelsang H Am J Gastroenterol; 1999 Mar; 94(3):685-90. PubMed ID: 10086652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]